<DOC>
	<DOCNO>NCT02319915</DOCNO>
	<brief_summary>Evaluate pharmacokinetic profile tranexamic acid inject intra-articularly without adrenaline , population patient undergoing knee replacement .</brief_summary>
	<brief_title>Evaluation Pharmacokinetic Profile Tranexamic Acid , After Injection Knee Neo-articulation .</brief_title>
	<detailed_description>Orthopedic population , especially knee surgery , risk significant bleed blood transfusion perioperative period . Tissue damage associate activation cascade mechanism , activation fibrinolyse play important role . This anti-fibrinolytic agent regularly use context reduce perioperative bleeding use blood transfusion . In majority case , tranexamic acid , analogue agent lysine , administer intravenous injection recently , intra-articular injection . Several question however remain unanswered . - clearance substance ? - intra-articular resorbtion exist , result plasmatic rate substance ? If yes , plasmatic rate ? - Is intra-articular effect tranexamic acid predominant compare systemic effect ? - Does addition adrenalin increase effect tranexamic acid act absorption ? The efficacy , safety well administration route tranexamic acid remain unknown injected intra-articularly . The goal study realize first pharmacokinetic study intra-articular injection tranexamic acid , alone along adrenalin , knee neo-articulation .</detailed_description>
	<mesh_term>Tranexamic Acid</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>program PTG , right leave surgery plan within CHU Brugmann Hospital ( Dr Reynders ) ASA I ASA III Signed informed consent within patient file redo surgery urgent multiple surgery ASA IV high Patients BMI superior equal 40 Patient Jehovah Witness Allergy contraindication tranexamic acid Coagulation trouble , define : Platelet count &lt; 80 000/mm3 and/or PTT &lt; 70 % and/or aPTT &gt; 45s and/or Fibrinogen &lt; 100mg/dL Preoperatory renal insufficiency define Creatinin &gt; 3mg/dL and/or Dialysis patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>tranexamic acid</keyword>
	<keyword>knee prosthesis</keyword>
	<keyword>pharmacokinetic profile</keyword>
</DOC>